Evaluation of the Acceptability (including Gastrointestinal Tolerance, Compliance and Palatability) of a High Energy Peptide Based Paediatric Oral Nutritional Supplement for Children Over 12 Months of Age
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Nutrition Disorder, Child
- Sponsor
- Société des Produits Nestlé (SPN)
- Enrollment
- 21
- Locations
- 1
- Primary Endpoint
- Gastrointestinal tolerance
- Status
- Completed
- Last Updated
- last year
Overview
Brief Summary
This is an acceptability study (including gastrointestinal tolerance, compliance and palatability) of a high energy peptide based paediatric oral nutritional supplement for children over 12 months of age.
The acceptability data from a minimum of 15 participants will be collected in order to submit an application to the Advisory Committee on Borderline Substances (ACBS).
Detailed Description
Fifteen (15) participants, aged 12 months and over, requiring a high energy peptide based oral nutritional supplement drink for the dietary management. The ACBS requirement for evaluable data on 15 participants has informed the trial's recruitment target; however, we may need to exceed this target if any patients give their consent to join the study but then decide not to participate in the study. Participants who join the study and begin using the product would count towards the recruitment total and their data would be included in a submission to the ACBS whether they complete the 7-day study period or not. Each potential participant must meet all of the inclusion criteria and not meet any of the exclusion criteria.
Investigators
Eligibility Criteria
Inclusion Criteria
- •I. Children aged 1 year and over who require 1-3 bottles of an oral nutritional peptide based supplement drink II. Children who require an oral nutritional supplement or who are already established on a nutritional supplement drink III. Children who require a nutritional supplement drink as bolus feeding via a feeding tube.
- •IV. Children being able to communicate views of acceptability V. Willingly given, written, informed consent from patient or parent/guardian. VI. Willingly given, written assent (if appropriate).
Exclusion Criteria
- •I. Inability to comply with the study protocol, in the opinion of the investigator.
- •II. Contraindications to any feed ingredients (see nutritional table and ingredients list) III. Require a milk free diet IV. Children under the age of 12 months V. Emergencies
Outcomes
Primary Outcomes
Gastrointestinal tolerance
Time Frame: Day 7 from baseline
Daily record via participant diary: 1. Gastrointestinal tolerance: * Diarrhoea and / or constipation * Bloating and / or distension * Nausea and / or vomiting * Burping / flatulence / regurgitation * Abdominal discomfort / pain/ back arching/ crying 2. Participant compliance: How many feeds taken and volume prescribed each day 3. Acceptability Questionnaires to children and or parents for the evaluation of the acceptability and ease of use of the milk supplement drink Diarrhoea, constipation, bloating, distension, nausea, vomitting, burping, abdominal pain
Compliance
Time Frame: Day 7 from baseline
volume suggested versus consumed
Secondary Outcomes
- weight in kg(Day 8 from baseline)
- height in meters(Day 8 from baseline)